J Bone Jt Infect 2019; 4(5):234-237. doi:10.7150/jbji.37980
Dalbavancin to Treat Infected Massive Endoprostheses: A Case Report and Cost Comparison Analysis
Royal National Orthopaedic Hospital
Azamgarhi T, Donaldson J, Shah A, Warren S. Dalbavancin to Treat Infected Massive Endoprostheses: A Case Report and Cost Comparison Analysis. J Bone Jt Infect 2019; 4(5):234-237. doi:10.7150/jbji.37980. Available from http://www.jbji.net/v04p0234.htm
We report a case of an infected massive endoprosthetic replacement treated successfully with 2 stage surgery and off-label dalbavancin. Dalbavancin was used due to a limited number of antimicrobial options that could be administered safely in an outpatient setting and to avoid the need for daily dosing.
Keywords: Periprosthetic joint infection, Lipoglycopeptide, Coagulase negative staphylococcus epidermidis, Osteomyelitis